NCT06275516 Safety and Efficacy of Multisensory Stimulation Virtual Reality for Stroke Patients.
| NCT ID | NCT06275516 |
| Status | Recruiting |
| Phase | — |
| Sponsor | First Affiliated Hospital of Chongqing Medical University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-03-20 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-03-20 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This was a single-blind randomized controlled trial of multisensory stimulation virtual reality to improve motor and cognitive dysfunction in stroke patients.
Eligibility Criteria
Inclusion Criteria: 1. The first onset of stroke is diagnosed and confirmed according to the requirements of stroke 2. The Fugl-Meyer Assessment of Lower Extremity (FMA-LE) is less than 34. 3. 18-85 years of age. 4. Able to walk with minor assistance 5. MMSE score of 20-30 and ability to understand and follow instructions during the trial 6. Able to sign an informed consent form. Exclusion Criteria: 1. Severe visual or hearing impairments. 2. Pregnant or breastfeeding women. 3. Patients with unrepaired cranial bone flaps or metallic implants following brain surgery. 4. Presence of other conditions affecting lower limb motor function, such as osteoarthritis or recent lower limb fractures. 5. History of severe psychiatric disorders, other neurological diseases, acute cardiopulmonary dysfunction, multiple organ failure, brain tumours, or epilepsy.
Contact & Investigator
Dingqun Bai
STUDY CHAIR
First Affiliated Hospital of Chongqing Medical University
Frequently Asked Questions
Who can join the NCT06275516 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06275516 currently recruiting?
Yes, NCT06275516 is actively recruiting participants. Contact the research team at baidingqun2014@163.com for enrollment information.
Where is the NCT06275516 trial being conducted?
This trial is being conducted at Chongqing, China.
Who is sponsoring the NCT06275516 clinical trial?
NCT06275516 is sponsored by First Affiliated Hospital of Chongqing Medical University. The principal investigator is Dingqun Bai at First Affiliated Hospital of Chongqing Medical University. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.